Retinoic acid-induced survival effects in SH-SY5Y neuroblastoma cells.

Neuroblastoma is a malignant childhood cancer arising from the embryonic sympathoadrenal lineage of the neural crest. Retinoic acid (RA) is included in the multimodal therapy of patients with high-risk neuroblastoma to eliminate minimal residual disease. However, the formation of RA-resistant cells substantially lowers 5-year overall survival rates. To examine mechanisms ...
that lead to treatment failure, we chose human SH-SY5Y cells, which are known to tolerate incubation with RA by activating the survival kinases Akt and extracellular signal-regulated kinase 1/2. Characterization of downstream pathways showed that both kinases increased the phosphorylation of the ubiquitin ligase mouse double minute homolog 2 (Mdm2) and thereby enhanced p53 degradation. When p53 signaling was sustained by blocking complex formation with Mdm2 or enhancing c-Jun N-terminal kinase (JNK) activation, cell viability was significantly reduced. In addition, Akt-mediated phosphorylation of the cell-cycle regulator p21 stimulated complex formation with caspase-3, which also contributed to cell protection. Thus, treatment with RA augmented survival signaling and attenuated basal apoptotic pathways in SH-SY5Y cells, which increased cell viability.
Mesh Terms:
Blotting, Western, Cell Line, Tumor, Cell Survival, Humans, Immunoprecipitation, Mitogen-Activated Protein Kinase 1, Mitogen-Activated Protein Kinase 3, Neuroblastoma, Plasmids, Proto-Oncogene Proteins c-akt, RNA, Small Interfering, Signal Transduction, Tretinoin, Tumor Suppressor Protein p53
J Cell Biochem
Date: Dec. 01, 2018
Download Curated Data For This Publication
227689
Switch View:
  • Interactions 2